KYMR Stock-Based Compensation
Kymera Therapeutics Inc · Stock-Based Compensation
KYMR Stock-Based Compensation
Latest reported$65.20Mperiod ending
KYMR Stock-Based Comp ($648.00K → $65.20M)
Annual stock-based compensation
High-resolution chart · PNG
KYMR stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 59,904,000 | |
| 55,012,000 | |
| 43,118,000 | |
| 35,480,000 | |
| 24,972,000 | |
| 5,190,000 | |
| 1,196,000 | |
| 648,000 |